KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Revenue (2016 - 2025)

Medpace Holdings' Revenue history spans 11 years, with the latest figure at $708.4 million for Q4 2025.

  • For Q4 2025, Revenue rose 32.03% year-over-year to $708.4 million; the TTM value through Dec 2025 reached $2.5 billion, up 19.97%, while the annual FY2025 figure was $2.5 billion, 19.97% up from the prior year.
  • Revenue reached $708.4 million in Q4 2025 per MEDP's latest filing, up from $659.9 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $708.4 million in Q4 2025 to a low of $260.0 million in Q1 2021.
  • Average Revenue over 5 years is $456.4 million, with a median of $476.7 million recorded in 2023.
  • Peak YoY movement for Revenue: soared 35.76% in 2021, then increased 7.66% in 2024.
  • A 5-year view of Revenue shows it stood at $308.6 million in 2021, then grew by 27.72% to $394.1 million in 2022, then grew by 26.47% to $498.4 million in 2023, then rose by 7.66% to $536.6 million in 2024, then skyrocketed by 32.03% to $708.4 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Revenue are $708.4 million (Q4 2025), $659.9 million (Q3 2025), and $603.3 million (Q2 2025).